The Journal of Infection in Developing Countries · 2009 · 20 citations · 16 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial PharmacotherapyAntimicrobial ResistanceMedical MicrobiologyAntibacterial ResistanceAntibiotic ResistanceAntimicrobial Susceptibility TestingBacterial InfectionsRespiratory InfectionsRespiratory Tract InfectionsAmoxicillin TherapyAntibacterial Susceptibility TestingAntibiotic Resistance In Respiratory PathogensBacterial Respiratory InfectionDrug Resistance Pattern AnalysisPathogen Susceptibility SurveillanceResistance Pattern MonitoringRespiratory Pathogen Surveillance
BACKGROUND: Haemophilus influenzae, Moraxella catarrhalis, Streptococcus pyogenes, and Streptococcus pneumoniae are the most common causative agents of respiratory tract infections (RTIs). The increase in resistance to current antibacterial agents highlights the need to monitor the resistance pattern of these bacterial pathogens. METHODOLOGY: In this study, we assessed the antibacterial susceptibility of these pathogens causing respiratory tract infections in Dakar, Senegal, during 2007-2008. A total of 290 bacterial isolates (75 H. influenzae, 10 M. catarrhalis, 105 S. pneumoniae, and 100 S. pyogenes) were collected. RESULTS AND CONCLUSIONS: All H. influenzae isolates were susceptible to amoxicillin/clavulanic acid, ofloxacin, clarithromycin, cephalosporins, and macrolides. Overall, 26.7% of H. influenzae isolates were completely resistant to ampicillin. Among the M. catarrhalis isolates, 30% were resistant to ampicillin. All the isolates of H. influenzae and M. catarrhalis that were resistant to ampicillin were beta-lactamase producing strains. Among the S. pneumoniae isolates, 33.3% isolates exhibited intermediate susceptibility to penicillin G, and one isolate was completely resistant. All five isolates that were resistant to erythromycin expressed the M phenotype. S. pyogenes exhibited high susceptibility to all other antibiotics, except tetracycline. Our study suggests that except for M. catarrhalis, all other bacterial isolates are susceptible to cephalosporins, macrolides, and fluroquinolones.
16
D. J. Hoban, G V Doern, A. C. Fluit et al. · Clinical Infectious Diseases · 2001 · 376 citations
D. Felmingham, R. N. Grüneberg · Journal of Antimicrobial Chemotherapy · 2000 · 368 citations · Full text
D. Felmingham, Ralf René Reinert, Yoichi Hirakata et al. · Journal of Antimicrobial Chemotherapy · 2002 · 221 citations · Full text
Rafael Cantón, Elena Loza, Ma Isabel Morosini et al. · Journal of Antimicrobial Chemotherapy · 2002 · 93 citations · Full text